Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea · Delayed Price · Currency is KRW 5,760.00
+30.00 (0.52%)
At close: Jan 23, 2026
Sinsin Pharmaceutical Revenue
Sinsin Pharmaceutical had revenue of 30.11B KRW in the quarter ending September 30, 2025, with 11.71% growth. This brings the company's revenue in the last twelve months to 110.29B, up 4.31% year-over-year. In the year 2024, Sinsin Pharmaceutical had annual revenue of 106.39B with 3.71% growth.
Revenue (ttm)
110.29B
Revenue Growth
+4.31%
P/S Ratio
0.79
Revenue / Employee
309.79M
Employees
356
Market Cap
87.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 106.39B | 3.80B | 3.71% |
| Dec 31, 2023 | 102.59B | 10.66B | 11.60% |
| Dec 31, 2022 | 91.93B | 17.92B | 24.21% |
| Dec 31, 2021 | 74.01B | 6.88B | 10.25% |
| Dec 31, 2020 | 67.13B | -725.72M | -1.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 300.96B |
| Cosmax Nbt | 293.75B |
| H.PIO | 257.56B |
| Daehan Nupharm | 201.59B |
| Hwail Pharmaceutical | 107.87B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 102.11B |
| Sinil Pharmaceutical | 80.97B |
| Sam-A Pharm. | 76.66B |